Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 2

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorWeill Medical College of Cornell University

About this trial

The goal of this Stage 1 (NIH Stage Model) Intervention Development cross-site project is to develop, using a user-centered design approach, and evaluate an innovative intelligent adaptive software package aimed at providing cognitive and social support and engagement to older adults with mild cognitive impairment (MCI). The system will be designed to adapt to the needs and abilities of the user. The investigator's goal is to develop a unique and highly innovative technology tool that can provide adaptive support to aging individuals with MCI, even as cognition might deteriorate further. Speech data collected as part of an embedded reminiscence feature will advance fundamental knowledge of how speech and language production data might serve as an early indicator of cognitive decline.

Eligibility criteria

Qualifiers

62+ years of age

Able to read English at the 6th grade level

Have 20/60 vision with or without correction.

Clinical diagnosis of mild cognitive impairment (MCI)

Disqualifiers

Blind or have visual impairments that limit their ability to view the technology.

Deaf or have hearing impairments that limit their ability to answer telephone queries.

Have a life-limiting/terminal illness

Severe motor impairment (e.g., severe tremors or debilitating arthritis in their hands) that impairs ability to speak or use dominant hand

Trial design

Treatments tested in this trial

  • Project 2, Phase 2: Intelligent Adaptive System

Treatment groups

290 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Weill Medical College of Cornell University

Lead sponsor

National Institute on Aging (NIA)

Collaborator